MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia

Clinical trial NCT04887311 · UNKNOWN

Trial details

NCT number: NCT04887311
Sponsor: Matrix Biomed, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ataxia Telangiectasia Louis-Bar Ataxia Telangiectasia in Children Ataxia Telangiectasia

Start date: 2021-07-01
Primary completion: 2022-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.